Revvity (RVTY) Other Accumulated Expenses (2014 - 2016)
Revvity's (RVTY) quarterly Other Accumulated Expenses came in at $126.1 million in Q1 2016, up 2.59% on a YoY basis from $123.0 million in Q1 2015, and up 2.59% quarter-over-quarter from $123.0 million in Q4 2014.
Powered by 
Analysis
Revvity (RVTY) Other Accumulated Expenses (2014 - 2016) Analysis & Trends
Revvity (RVTY) has reported Other Accumulated Expenses for 2 consecutive years, with $126.1 million the latest figure, recorded in Q1 2016.
- For the quarter ending Q1 2016, Other Accumulated Expenses rose 2.59% year-over-year to $126.1 million; the trailing twelve-month figure through Jan 2016 stood at $126.1 million (up 2.59% YoY), and the FY2016 full-year result was $126.1 million, up 2.59% from the prior year.
- Other Accumulated Expenses climbed to $126.1 million in Q1 2016 per RVTY's latest filing, from $123.0 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $126.1 million in Q1 2016 and bottomed at $123.0 million in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |